TAVI: Edwards lands FDA approval for next-gen Sapien XT

Edwards Lifesciences wins FDA approval for its next-generation Sapien XT transcatheter valve implantation system in high-risk and inoperable patients.

Edwards Lifesciences, Food & Drug Administration (FDA)

News Well, Regulatory/Clearance, Pre-Market Approval (PMA), Replacement Heart Valves

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sjSLDG